William Maughan
Stock Analyst at Clear Street
(4.23)
# 1,469
Out of 5,023 analysts
145
Total ratings
41.7%
Success rate
12.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Reiterated: Buy | $28 | $6.96 | +302.30% | 8 | Aug 18, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $18 | $9.64 | +86.72% | 6 | Aug 7, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $37 | $24.50 | +51.02% | 6 | Aug 5, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $130 | $88.21 | +47.38% | 3 | Aug 5, 2026 | |
| KRYS Krystal Biotech | Reiterated: Buy | $338 → $311 | $322.28 | -3.50% | 5 | May 4, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $32 → $31 | $16.76 | +85.02% | 6 | May 1, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $39 → $36 | $3.78 | +852.38% | 7 | Apr 28, 2026 | |
| ANNX Annexon | Reiterated: Buy | $17 | $4.19 | +305.73% | 2 | Mar 30, 2026 | |
| CLLS Cellectis | Reiterated: Buy | $9 | $1.43 | +529.37% | 2 | Mar 20, 2026 | |
| IPSC Century Therapeutics | Reiterated: Buy | $6.6 | $1.53 | +331.37% | 10 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.91 | +104.60% | 4 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $181 → $167 | $96.90 | +72.34% | 21 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.6 | $2.62 | +75.57% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $1.22 | +965.57% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $7.43 | +505.65% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $27 | $15.13 | +78.45% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $50 | $55.43 | -9.80% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $67 | $29.71 | n/a | 4 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $8.23 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $9 | $2.32 | n/a | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $15 | $2.58 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $24.84 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 → $106 | $190.01 | n/a | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $3.38 | n/a | 7 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $5 | $25.65 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $219.88 | n/a | 1 | Sep 5, 2022 |
Ocular Therapeutix
Aug 18, 2026
Reiterated: Buy
Price Target: $28
Current: $6.96
Upside: +302.30%
Korro Bio
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $9.64
Upside: +86.72%
Beam Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $37
Current: $24.50
Upside: +51.02%
Dianthus Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $130
Current: $88.21
Upside: +47.38%
Krystal Biotech
May 4, 2026
Reiterated: Buy
Price Target: $338 → $311
Current: $322.28
Upside: -3.50%
Summit Therapeutics
May 1, 2026
Reiterated: Buy
Price Target: $32 → $31
Current: $16.76
Upside: +85.02%
Wave Life Sciences
Apr 28, 2026
Reiterated: Buy
Price Target: $39 → $36
Current: $3.78
Upside: +852.38%
Annexon
Mar 30, 2026
Reiterated: Buy
Price Target: $17
Current: $4.19
Upside: +305.73%
Cellectis
Mar 20, 2026
Reiterated: Buy
Price Target: $9
Current: $1.43
Upside: +529.37%
Century Therapeutics
Mar 13, 2026
Reiterated: Buy
Price Target: $6.6
Current: $1.53
Upside: +331.37%
Mar 13, 2026
Reiterated: Buy
Price Target: $8
Current: $3.91
Upside: +104.60%
Mar 11, 2026
Reiterated: Buy
Price Target: $181 → $167
Current: $96.90
Upside: +72.34%
Mar 10, 2026
Reiterated: Buy
Price Target: $4.6
Current: $2.62
Upside: +75.57%
Mar 6, 2026
Reiterated: Buy
Price Target: $13
Current: $1.22
Upside: +965.57%
Mar 6, 2026
Reiterated: Buy
Price Target: $45
Current: $7.43
Upside: +505.65%
Feb 26, 2026
Reiterated: Buy
Price Target: $29 → $27
Current: $15.13
Upside: +78.45%
Nov 11, 2025
Reiterated: Hold
Price Target: $45 → $50
Current: $55.43
Upside: -9.80%
May 23, 2024
Reiterated: Hold
Price Target: $67
Current: $29.71
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $24
Current: $8.23
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $11 → $9
Current: $2.32
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $16 → $15
Current: $2.58
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $38
Current: $24.84
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: $91 → $106
Current: $190.01
Upside: n/a
Feb 20, 2024
Reiterated: Buy
Price Target: $60
Current: $3.38
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $10 → $5
Current: $25.65
Upside: n/a
Sep 5, 2022
Reiterated: Buy
Price Target: n/a
Current: $219.88
Upside: n/a